“IL-2, IFN-?³ and anti-HBs based Immune Responses to Hepatitis B Vaccine in Type 2 Diabetic Patients”, J. Medicine, vol. 17, no. 1, pp. 8–11, Oct. 2016, doi: 10.3329/jom.v17i1.30051.